Page 16 - Anjali Singh

CDMOs gear up for peptide boom amid rising demand for weight-loss drugs

With global demand for GLP-1-based drugs rising, Indian CDMOs are ramping up peptide capabilities ahead of key patent expiries such as that of semaglutide in 2026

EV startup MATTER launches ₹1.93 lakh Aera 5000+ e-bike, eyes IPO

Ahmedabad-based MATTER aims to disrupt the 150-200cc bike segment with its Aera 5000+, backed by global investors and planning a $200 million fundraising and public listing

Cipla buys 20% stake in iCaltech to broaden respiratory device portfolio

Cipla has acquired a 20% stake in iCaltech Innovations for Rs 5 crore, expanding its presence in the respiratory diagnostics segment with a strategic investment in medical device development

Renault Group names Stephane Deblaise as new CEO for India operations

Renault Group appoints Stephane Deblaise as the new CEO for India operations, effective September 1, 2025, as part of the company's strategy to enhance growth in the Indian market

Renault to launch all-new models with updated logo, starting with Triber

Renault India will feature its updated interlocked diamond logo on future models, beginning with the launch of the all-new Triber, as part of its ongoing brand transformation

Sun Pharma's psoriasis drug delivers positive results in arthritis trials

Sun Pharma's psoriasis drug Ilumya shows promising results in late-stage psoriatic arthritis trials, paving the way for potential regulatory filings and expansion into the immunology market.

Tyre industry to grow 7-8% in FY26, driven by replacement demand: Crisil

Crisil expects India's Rs 1 trillion tyre industry to grow 7-8% in FY26, mainly driven by replacement demand, while OEM volumes and global trade risks continue to pose challenges

CORONA Remedies acquires 7 pharma brands from Bayer India, plans expansion

CORONA Remedies deepens footprint in women's healthcare and cardiology with Bayer India portfolio acquisition, entering anti-platelet and hormone therapy segments

Ceat Q1FY26: Profit declines 27% on higher costs, revenue rises 10.5%

Ceat Q1 net profit declines 27 per cent due to IPL-linked marketing spends and higher input costs even as revenue rises 10.5 per cent on strong OEM and replacement demand

Curtains rise today on Tesla's India foray; Model Y tipped as flagbearer

Real estate analysts watching Tesla's impact on rentals closely

Temasek's India exposure hits $50 bn, eyes $3-4 bn annual investments

Temasek Holdings increases its India exposure to $50 billion by March 2025, with plans to invest $3-4 billion annually, focusing on sectors like financial services, healthcare, and sustainability

UK company AEM set to bring rare-earth-free technology to India

The firm has partnered with Sterling Tools Limited's EV arm, Sterling Gtake Electro Mobility (SGEM), to localise production and assembly of its traction motors at SGEM's Faridabad facility

Used-car sales to expand 8-10% in FY26, outpace new vehicles: Crisil

The used-to-new car sales ratio has increased to 1.4 from less than 1 five years ago. The market value of these used cars is estimated to be around Rs 4 trillion, nearly matching that of new car sales

Glenmark arm inks $700 million licensing deal with US-based AbbVie

IGI Therapeutics, a wholly owned subsidiary of Glenmark, has licensed its cancer and autoimmune drug ISB 2001 to AbbVie for an upfront payment of $700 million

Daimler Truck targets over 60,000 units to scale up operations by 2030

India to become a strategic base for Daimler Truck's global operations in manufacturing, R&D and exports under its Unlock Full Potential transformation plan

Anthem Biosciences expands manufacturing capacity ahead of ₹3,395-cr IPO

CRDMO firm Anthem Biosciences expands peptide and API production, with Unit 4 under development, as it prepares for a Rs 3,395-crore IPO opening on July 14

India's electric vehicle sales surged in June; slow start for e2Ws: Fada

India's EV market continued to expand in June 2025, with a notable rise in passenger vehicle sales. However, the two-wheeler segment saw a dip in H1 performance due to a weak start to the year

Tata Motors' global wholesales fall 9% in Q1, led by JLR and PV segments

Tata Motors Group's global wholesales fell 9% YoY in Q1 FY26, reaching 2,99,664 units, with declines in both commercial and passenger vehicles, including Jaguar Land Rover (JLR).

JLR reports Q1 sales decline due to Jaguar phase-out and US tariffs

Jaguar Land Rover (JLR) reports a 10.7% drop in Q1 FY26 wholesale volumes and 15.1% decline in retail sales, citing the Jaguar phase-out and US import tariffs as major factors.

OLX India launches Elite Buyer plan to improve second-hand deals

The subscription-based Elite Buyer Program gives users category-specific tags and verified leads to speed up responses and boost trust in second-hand transactions